Bio-Gene Technology Limited

Informe acción ASX:BGT

Capitalización de mercado: AU$14.1m

Bio-Gene Technology Dirección

Dirección controles de criterios 0/4

El CEO de Bio-Gene Technology's es Tim Grogan, nombrado en Aug 2023, tiene una permanencia de menos de un año. posee directamente un 0.03% de las acciones de la empresa, con un valor de A$4.46K. La antigüedad media del equipo directivo y de la junta directiva es de 0.7 años y 1 años, respectivamente.

Información clave

Tim Grogan

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEO0.03%
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directivaless than a year

Actualizaciones recientes de la dirección

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

CEO

Tim Grogan

less than a year

Permanencia

Mr. Timothy Owen Grogan, LLB, B.Sc., also known as Tim, serves as Managing Director, Chief Executive Officer & Director of Bio-Gene Technology Limited since August 28, 2023. He serves as a Director of Cons...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Roger McPherson
Interim CFO & Company Secretaryless than a yearAU$146.51k0.61%
A$ 85.7k
Peter May
Executive Director of Research & Development and Executive Director6.3yrsAU$246.25k0.91%
A$ 129.0k
Timothy Grogan
MD, CEO & Directorless than a yearsin datos0.030%
A$ 4.2k

0.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de BGT no se considera experimentado ( 0.7 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Peter May
Executive Director of Research & Development and Executive Director8.9yrsAU$246.25k0.91%
A$ 129.0k
Timothy Grogan
MD, CEO & Directorless than a yearsin datos0.030%
A$ 4.2k
Douglas Rathbone
Adviser to the Board6.3yrssin datossin datos
Peter Beetham
Member of Scientific Advisory Boardless than a yearAU$45.50k0.030%
A$ 4.2k
Andrew Guthrie
Non-Executive Director3yrsAU$57.62k0.13%
A$ 18.7k
Catherine Hill
Member of the Scientific Advisory Board6.2yrssin datossin datos
Neil Anderson
Member of Scientific Advisory Boardno datasin datossin datos
Andrew Bartholomaeus
Member of Scientific Advisory Boardno datasin datossin datos
Huong Soo Ding
Non-Executive Chairmanless than a yearAU$6.97k0.060%
A$ 8.5k
Christopher Ramsay
Non-Executive Directorless than a yearAU$6.97ksin datos
Chris Ramsey
Non Executive Directorless than a yearsin datos0.059%
A$ 8.3k

1.0yrs

Permanencia media

Junta con experiencia: La junta directiva de BGT no se considera experimentada (1 años de permanencia promedio), lo que sugiere una nueva junta directiva.